Changli Peng

417 total citations
8 papers, 324 citations indexed

About

Changli Peng is a scholar working on Hepatology, Surgery and Molecular Biology. According to data from OpenAlex, Changli Peng has authored 8 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hepatology, 3 papers in Surgery and 2 papers in Molecular Biology. Recurrent topics in Changli Peng's work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Liver Disease and Transplantation (2 papers). Changli Peng is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Liver Disease and Transplantation (2 papers). Changli Peng collaborates with scholars based in China and United States. Changli Peng's co-authors include Chunhui Zhou, Liangrong Shi, Yibei Zhu, Changping Wu, Hongbing Shi, Nianhua Ding, Junjun Wang, Yi Zhang, Xiaodong Li and Ledu Zhou and has published in prestigious journals such as Nature Communications, Clinical Cancer Research and International Journal of Hydrogen Energy.

In The Last Decade

Changli Peng

8 papers receiving 320 citations

Peers

Changli Peng

ONCOL

IMMUN

HEPAT

MC

MB

Shoujie Zhao China

Shiyi Shao China

Shengxin Huang China

Huaiming Wang China

Chih-Chun Chang Taiwan

Yahui Liu China

Chunlei Dai China

Man Shu China

Rongpu Liang China

Beini Cen China

Shoujie Zhao China

Changli Peng

66 ×0.6

ONCOL

58 ×0.6

IMMUN

123 ×1.8

HEPAT

137 ×2.0

MC

202 ×3.1

MB

Citations per year, relative to Changli Peng Changli Peng (= 1×) peers Shoujie Zhao

Countries citing papers authored by Changli Peng

Since Specialization

Citations

This map shows the geographic impact of Changli Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changli Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changli Peng more than expected).

Fields of papers citing papers by Changli Peng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changli Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changli Peng. The network helps show where Changli Peng may publish in the future.

Co-authorship network of co-authors of Changli Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Changli Peng. A scholar is included among the top collaborators of Changli Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changli Peng. Changli Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Li, Yan, Jiaping Li, Bin Liang, et al.. (2023). A Phase 1/2 Multicenter Randomized Trial of Local Ablation plus Toripalimab versus Toripalimab Alone for Previously Treated Unresectable Hepatocellular Carcinoma. Clinical Cancer Research. 29(15). 2816–2825. 14 indexed citations

2.

Zhou, Chunhui, Haiping Li, Changyong Chen, et al.. (2023). Transjugular Intrahepatic Portosystemic Shunt Benefits for Hepatic Sinusoidal Obstruction Syndrome Associated with Consumption of Gynura Segetum: a Propensity Score-Matched Analysis. CardioVascular and Interventional Radiology. 46(7). 931–942. 2 indexed citations

3.

Peng, Changli, et al.. (2023). Evaluation of the efficacy and safety of CalliSpheres® microsphere-transarterial chemoembolization in large hepatocellular carcinoma. Journal of Cancer Research and Therapeutics. 19(6). 1575–1581. 1 indexed citations

4.

Peng, Changli, Bin Xu, Chunhui Zhou, et al.. (2021). Hepatic Artery Infusion of Floxuridine in Combination With Systemic Chemotherapy for Pancreatic Cancer Liver Metastasis: A Propensity Score-Matched Analysis in Two Centers. Frontiers in Oncology. 11. 652426–652426. 8 indexed citations

5.

Peng, Changli, Yongjin Zou, Cuili Xiang, et al.. (2020). Bacterial cellulose derived carbon as a support for catalytically active Co–B alloy for hydrolysis of sodium borohydride. International Journal of Hydrogen Energy. 46(1). 666–675. 68 indexed citations

6.

Zhou, Chunhui, Zhen Chen, Changli Peng, Changyong Chen, & Haiping Li. (2020). Long Noncoding RNA TRIM52-AS1 Sponges miR-514a-5p to Facilitate Hepatocellular Carcinoma Progression Through Increasing MRPS18A. Cancer Biotherapy and Radiopharmaceuticals. 36(2). 211–219. 23 indexed citations

7.

Shi, Liangrong, Junjun Wang, Nianhua Ding, et al.. (2019). Inflammation induced by incomplete radiofrequency ablation accelerates tumor progression and hinders PD-1 immunotherapy. Nature Communications. 10(1). 5421–5421. 203 indexed citations

8.

Peng, Changli, et al.. (2019). Hepatic artery infusion pump for nasopharyngeal carcinoma with liver metastasis. Clinical & Experimental Metastasis. 37(2). 333–339. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact